Association Between Percutaneous Ventricular Assist Device Hospital Volumes and In-hospital Outcomes.
Association Between Percutaneous Ventricular Assist Device Hospital Volumes and In-hospital Outcomes.
Monday, May 20, 2019
Belmont Ballroom 2-3 (The Cosmopolitan of Las Vegas)
Background:
Methods
:Using the National Readmission Database from 2010 to 2015, we identify adult patients that underwent pVAD placement using ICD-9 DM codes and divided them into low-moderate volume centers (≤ 12 pVAD/year) and high-volume centers (>12 pVAD/year). We used multivariate logistic regression to compare mortality, readmission rates and in-hospital outcomes between both groups.
Results
:We included 1,671 hospitals (121 categorized as high-volume and 1,450 as low-moderate volume) which comprised 17,218 patients (5,073 admitted to high-volume and 12,145 admitted to low-moderate volume hospitals). In-hospital mortality was significantly lower in high-volume centers when compared to low-moderate volume centers (32.1 % vs 35.9%, OR 0.77, 95%CI 0.65-0.92, p=0.003), as was vascular complications (25.5% vs 28.7%, OR 0.80, 95%CI 0.67-0.94, p=0.008) and cardiac complications (7.5% vs 9.1%, OR 0.73, 95%CI 0.56-0.96, p=0.025). High volume centers also had lower hospital costs ($63,205 vs $67,329, p=0.016). There was no significant difference in 30-day readmissions, 30-day mortality, stroke rates, major bleeding, acute kidney injury and length of stay.
Conclusions
:Hospitals with higher pVAD volume had lower in-hospital mortality, vascular complications, cardiac complications and lower hospital costs when compared with low-moderate volume hospitals.